SynKIR-310 for Relapsed/Refractory B-NHL
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Large B-cell Lymphoma
Related studies linked through entity extraction aliases.
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
- Status
- RECRUITING
- Phase
- PHASE2
Relmacabtagene Autoleucel in Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Relmacabtagene Autoleucel in Patients With LBCL
- Status
- RECRUITING
- Phase
- N/A
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
- Status
- RECRUITING
- Phase
- NA
An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2